Chinese consensus on the clinical application of hepatobiliary magnetic resonance imaging contrast agent: Gadoxetic acid disodium.

The article focuses on the hepatobiliary contrast agent gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) helping to characterize focal liver lesions. It discusses the recommendation of dynamic contrast-enhanced multislice computed tomography (MSCT) by the American Association for the Study of Liver Diseases.